76 related articles for article (PubMed ID: 18630502)
1. A comparison of two orally bioavailable anti-cancer agents, IRC-110160 and STX140.
Foster PA; Stengel C; Ali T; Leese MP; Potter BV; Reed MJ; Purohit A; Newman SP
Anticancer Res; 2008; 28(3A):1483-91. PubMed ID: 18630502
[TBL] [Abstract][Full Text] [Related]
2. STX140 is efficacious in vitro and in vivo in taxane-resistant breast carcinoma cells.
Newman SP; Foster PA; Stengel C; Day JM; Ho YT; Judde JG; Lassalle M; Prevost G; Leese MP; Potter BV; Reed MJ; Purohit A
Clin Cancer Res; 2008 Jan; 14(2):597-606. PubMed ID: 18223236
[TBL] [Abstract][Full Text] [Related]
3. 2-Methoxyoestradiol-3,17-O,O-bis-sulphamate and 2-deoxy-D-glucose in combination: a potential treatment for breast and prostate cancer.
Tagg SL; Foster PA; Leese MP; Potter BV; Reed MJ; Purohit A; Newman SP
Br J Cancer; 2008 Dec; 99(11):1842-8. PubMed ID: 18985042
[TBL] [Abstract][Full Text] [Related]
4. A new micronized formulation of 2-methoxyestradiol-bis-sulfamate (STX140) is therapeutically potent against breast cancer.
Foster PA; Newman SP; Leese MP; Bernetiere S; Diolez C; Camara J; Hacher B; Baronnet MM; Ali T; Potter BV; Reed MJ; Purohit A
Anticancer Res; 2008; 28(2A):577-81. PubMed ID: 18506995
[TBL] [Abstract][Full Text] [Related]
5. The therapeutic potential of a series of orally bioavailable anti-angiogenic microtubule disruptors as therapy for hormone-independent prostate and breast cancers.
Newman SP; Foster PA; Ho YT; Day JM; Raobaikady B; Kasprzyk PG; Leese MP; Potter BV; Reed MJ; Purohit A
Br J Cancer; 2007 Dec; 97(12):1673-82. PubMed ID: 18026194
[TBL] [Abstract][Full Text] [Related]
6. 2-MeOE2bisMATE and 2-EtE2bisMATE induce cell cycle arrest and apoptosis in breast cancer xenografts as shown by a novel ex vivo technique.
Foster PA; Ho YT; Newman SP; Kasprzyk PG; Leese MP; Potter BV; Reed MJ; Purohit A
Breast Cancer Res Treat; 2008 Sep; 111(2):251-60. PubMed ID: 17957467
[TBL] [Abstract][Full Text] [Related]
7. RL66 a second-generation curcumin analog has potent in vivo and in vitro anticancer activity in ER‑negative breast cancer models.
Yadav B; Taurin S; Larsen L; Rosengren RJ
Int J Oncol; 2012 Nov; 41(5):1723-32. PubMed ID: 22971638
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of cell survival, cell cycle progression, tumor growth and cyclooxygenase-2 activity in MDA-MB-231 breast cancer cells by camphorataimide B.
Lin WL; Lee YJ; Wang SM; Huang PY; Tseng TH
Eur J Pharmacol; 2012 Apr; 680(1-3):8-15. PubMed ID: 22329896
[TBL] [Abstract][Full Text] [Related]
9. VP-128, a novel oestradiol-platinum(II) hybrid with selective anti-tumour activity towards hormone-dependent breast cancer cells in vivo.
Van Themsche C; Parent S; Leblanc V; Descôteaux C; Simard AM; Bérubé G; Asselin E
Endocr Relat Cancer; 2009 Dec; 16(4):1185-95. PubMed ID: 19661132
[TBL] [Abstract][Full Text] [Related]
10. The In Vitro and In Vivo Activity of the Microtubule Disruptor STX140 Is Mediated by Hif-1 Alpha and CAIX Expression.
Stengel C; Newman SP; Leese MP; Thomas MP; Potter BV; Reed MJ; Purohit A; Foster PA
Anticancer Res; 2015 Oct; 35(10):5249-61. PubMed ID: 26408684
[TBL] [Abstract][Full Text] [Related]
11. CEP-7055: a novel, orally active pan inhibitor of vascular endothelial growth factor receptor tyrosine kinases with potent antiangiogenic activity and antitumor efficacy in preclinical models.
Ruggeri B; Singh J; Gingrich D; Angeles T; Albom M; Yang S; Chang H; Robinson C; Hunter K; Dobrzanski P; Jones-Bolin S; Pritchard S; Aimone L; Klein-Szanto A; Herbert JM; Bono F; Schaeffer P; Casellas P; Bourie B; Pili R; Isaacs J; Ator M; Hudkins R; Vaught J; Mallamo J; Dionne C
Cancer Res; 2003 Sep; 63(18):5978-91. PubMed ID: 14522925
[TBL] [Abstract][Full Text] [Related]
12. Antitumor activity of orally bioavailable farnesyltransferase inhibitor, ABT-100, is mediated by antiproliferative, proapoptotic, and antiangiogenic effects in xenograft models.
Ferguson D; Rodriguez LE; Palma JP; Refici M; Jarvis K; O'Connor J; Sullivan GM; Frost D; Marsh K; Bauch J; Zhang H; Lin NH; Rosenberg S; Sham HL; Joseph IB
Clin Cancer Res; 2005 Apr; 11(8):3045-54. PubMed ID: 15837760
[TBL] [Abstract][Full Text] [Related]
13. BCRP expression does not result in resistance to STX140 in vivo, despite the increased expression of BCRP in A2780 cells in vitro after long-term STX140 exposure.
Day JM; Foster PA; Tutill HJ; Newman SP; Ho YT; Leese MP; Potter BV; Reed MJ; Purohit A
Br J Cancer; 2009 Feb; 100(3):476-86. PubMed ID: 19156141
[TBL] [Abstract][Full Text] [Related]
14. Targeting of nuclear factor kappaB Pathways by dehydroxymethylepoxyquinomicin, a novel inhibitor of breast carcinomas: antitumor and antiangiogenic potential in vivo.
Matsumoto G; Namekawa J; Muta M; Nakamura T; Bando H; Tohyama K; Toi M; Umezawa K
Clin Cancer Res; 2005 Feb; 11(3):1287-93. PubMed ID: 15709200
[TBL] [Abstract][Full Text] [Related]
15. STX140, but not paclitaxel, inhibits mammary tumour initiation and progression in C3(1)/SV40 T/t-antigen transgenic mice.
Meyer-Losic F; Newman SP; Day JM; Reed MJ; Kasprzyk PG; Purohit A; Foster PA
PLoS One; 2013; 8(12):e80305. PubMed ID: 24324595
[TBL] [Abstract][Full Text] [Related]
16. Luteolin exerts anti-tumor activity through the suppression of epidermal growth factor receptor-mediated pathway in MDA-MB-231 ER-negative breast cancer cells.
Lee EJ; Oh SY; Sung MK
Food Chem Toxicol; 2012 Nov; 50(11):4136-43. PubMed ID: 22926442
[TBL] [Abstract][Full Text] [Related]
17. 3,3'-Diindolylmethane negatively regulates Cdc25A and induces a G2/M arrest by modulation of microRNA 21 in human breast cancer cells.
Jin Y; Zou X; Feng X
Anticancer Drugs; 2010 Oct; 21(9):814-22. PubMed ID: 20724916
[TBL] [Abstract][Full Text] [Related]
18. 1,1-Bis(3'-indolyl)-1-(p-substituted phenyl)methanes inhibit proliferation of estrogen receptor-negative breast cancer cells by activation of multiple pathways.
Vanderlaag K; Su Y; Frankel AE; Grage H; Smith R; Khan S; Safe S
Breast Cancer Res Treat; 2008 May; 109(2):273-83. PubMed ID: 17624585
[TBL] [Abstract][Full Text] [Related]
19. Potent combination therapy for human breast tumors with high doses of 5-fluorouracil: remission and lack of host toxicity.
Al Safarjalani ON; Rais R; Naguib FN; el Kouni MH
Cancer Chemother Pharmacol; 2012 Jun; 69(6):1449-55. PubMed ID: 22373605
[TBL] [Abstract][Full Text] [Related]
20. Green tea polyphenols and its constituent epigallocatechin gallate inhibits proliferation of human breast cancer cells in vitro and in vivo.
Thangapazham RL; Singh AK; Sharma A; Warren J; Gaddipati JP; Maheshwari RK
Cancer Lett; 2007 Jan; 245(1-2):232-41. PubMed ID: 16519995
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
